Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 62.8

(7.72%)

Long Term Debt Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual long term debt in 2023 was - TWD , down -100.0% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly long term debt in 2024 Q2 was 3.06 Million TWD , down 0.0% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported annual long term debt of 3.94 Million TWD in 2022, down -36.28% from previous year.
  • Energenesis Biomedical CO.,LTD. reported annual long term debt of 6.19 Million TWD in 2021, down -36.41% from previous year.
  • Energenesis Biomedical CO.,LTD. reported quarterly long term debt of 4.15 Million TWD for 2024 Q1, down 0.0% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported quarterly long term debt of 4.38 Million TWD for 2023 Q3, up 91.06% from previous quarter.

Annual Long Term Debt Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Historical Annual Long Term Debt of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - TWD -100.0%
2022 3.94 Million TWD -36.28%
2021 6.19 Million TWD -36.41%
2020 9.73 Million TWD 8.64%
2019 8.96 Million TWD 0.0%

Peer Long Term Debt Comparison of Energenesis Biomedical CO.,LTD.

Name Long Term Debt Long Term Debt Difference
Apex Biotechnology Corp. 116.19 Million TWD 100.0%
Sinphar Pharmaceutical Co.,Ltd. 1.49 Billion TWD 100.0%
Panion & Bf Biotech Inc. 125.41 Million TWD 100.0%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 700 Million TWD 100.0%
GenMont Biotech Incorporation 20.11 Million TWD 100.0%
Abnova (Taiwan) Corporation 2.6 Million TWD 100.0%
Adimmune Corporation 1.91 Billion TWD 100.0%
Tanvex BioPharma, Inc. 1.56 Billion TWD 100.0%
Polaris Group 352.96 Million TWD 100.0%
UnicoCell Biomed Co., Ltd. 68.23 Million TWD 100.0%
PELL Bio-Med Technology Co. Ltd. 147.46 Million TWD 100.0%